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ABSTRACTS 
Objective: Anticancer activity of methanol extract of Hippophae salicifolia (MEHS) bark was evaluated using the Ehrlich Ascites Carcinoma (EAC) 
cells on Swiss albino mice.  
Methods: In vitro cytotoxicity assay has been evaluated by using the trypan blue and MTT assay method. The determination of in vivo anticancer 
activity was performed using EAC cells (2 × 106
Results: In MEHS treated groups (50 and 100 mg/kg b. w.) tumor volume, tumor weight, viable cell count was significantly decreased as compared to 
that of the EAC control group. Life span increased by 34% and 43% in a dose dependant manner as compared to EAC control group. The hematological, 
biochemical and liver tissue antioxidant parameter are significantly (p < 0.05) restored towards the normal level after treatment with MEHS. 
) induced mice groups (n = 12). After treatment with MEHS at the doses of 50 and 100 mg/kg b. w. 
respectively for 9 days, half of the mice of each group were sacrificed and the rest were kept for increase in life span determination. The anticancer 
potential of MEHS was assessed by evaluating tumor volume, viable and nonviable tumor cell count, tumor weight, hematological parameters and 
biochemical estimations. Furthermore, tissue antioxidant parameters were checked from liver homogenate. 
Conclusion: From the above study it can be concluded that the MEHS has significant anticancer activity in the dose dependent manner. 
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INTRODUCTION 
Cancer has wreaked havoc in terms of mortality over years and the 
number of people affected with cancer is steadily increasing every 
day [1]. An estimate of 14.1 million new cancer cases, 8.2 million 
cancer deaths and 32.6 million people living with cancer (within 5 
years of diagnosis) in 2012 worldwide was observed. 57% (8 
million) of new cancer cases, 65% (5.3 million) of the cancer deaths 
and 48% (15.6 million) of the 5-year prevalent cancer cases 
occurred in the less developed regions [2]. Naturally current 
pharmacological research focuses on discovering new drugs or 
compounds to fight cancer. Nature has been providing man with 
remedies to diseases since time immemorial. Natural sources like 
plants and marine products can synthesize a variety of structurally 
and functionally diverse bioactive compounds which can mitigate a 
varied number of ailments including cancer. Several plant products 
like taxol, vincristine etc have proven anticancer activities and are 
now available in the market for cancer treatment [3].  
Hippophae salicifolia, commonly known as Sea-buckthorn, is a versatile 
plant with multipurpose uses. In India, two species of Sea-buckthorn, 
namely, Hippophae salicifolia D. Don and Hippophae rhamnoides L. are 
very common. H. salicifolia is a shrub-to-tree in nature and is restricted 
to the Himalayan region, whereas H. rhamnoides is bushy, growing at 
higher altitude in India, and widely distributed in Europe and Asia [4]. 
The bark is traditionally used for its anti diarrhoeal, antitumor and 
cosmetic purposes and also its ash has burn healing properties [5]. It has 
been reported that the plant has anti bacterial and anti fungal activities 
[6]. The hydro alcoholic extract of bark has also shown the antioxidant 
activity [7]. 
MATERIALS AND METHODS 
The present study was carried out to evaluate the anticancer 
effect of the methanol extract of Hippophae salicifolia bark against 
Ehrlich’s Ascites Carcinoma (EAC) in Swiss albino mice. 
Chemicals 
Sodium chloride, Propylene glycol, Trypan blue, Methyl violet, 
Sodium sulphate, Methylene blue, 5-Fluorouracil, MTT (MERCK 
Limited, Mumbai, India). All other chemicals and reagents used were 
of highest analytical grade.  
Plant collection and extraction 
Hippophae salicifolia barks were collected from the Gangtok, Sikkim, 
India. The barks were cleaned and air dried for a week at 35–40°C 
and pulverized in electric grinder. Coarse bark (1.4 kg) was 
extracted by methanol (13.8% w/w, yield) by using soxhlet 
apparatus. The solvents were completely removed under reduced 
pressure in a rotary vacuum evaporator (Buchi R-210). The 
concentrated extracts were stored in vacuum desiccators for further 
use. 
Animals 
Male Swiss albino mice weighing 20–22 g were taken. They were 
obtained from the animal house, B. N. Ghosh & Co. Kolkata, India. 
The mice were grouped and housed in poly acrylic cages (38 × 23 × 
10 cm) with not more than 6 animals per cage and maintained under 
standard laboratory conditions (temperature 25 ± 2 °C and dark/ 
light cycle 14/10 h). They were allowed free access to standard dry 
pellet diet (Hindustan Lever, Kolkata, India) and water ad libitum. 
The mice were acclimatized to laboratory conditions for 7 days 
before commencement of the experiment. All procedures described 
were reviewed and approved by the University Animal Ethical 
Committee. 
Transplantation of tumor cell 
Ehrlich ascites tumor cells were maintained in our laboratory 
according to the standard protocol. EAC cells were obtained from 
Chittaranjan National Cancer Institute (CNCI), Kolkata, India. The 
EAC cells were maintained in vivo in Swiss albino mice by 
intraperitoneal transplantation of 2 × 106 cells per mouse after every 
10 days. Ascitic fluid was drawn out from EAC tumor bearing mouse 
at the log phase (day 7 – 8 of tumor bearing) of the tumor cells. Each 
animal received 0.1 ml of tumor cell suspension containing 2×106 
EAC cells intra peritoneally [8]. 
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Determination of in vitro cytotoxicity 
In vitro cytotoxicity studies of MEHS were done by standard trypan 
blue (0.4%) exclusion method and MTT assay [8, 9]. The experiment 
was performed in triplicate. 
Determination of acute toxicity 
The acute oral toxicity of MEHS in Swiss albino mice was performed 
as per OECD guideline 425 (OECD, 2008) [10]. 
Treatment schedule  
Swiss albino mice (60) were divided into five groups (n = 12). All the 
animals in each group, except Group-I (Normal control) received EAC 
cells (2 × 106
Determination of biochemical parameters 
 cells/mouse i. p.). This was taken as day ‘0’. Group-I served 
as normal saline (5 ml/kg i. p.) and group-II (EAC control) served as EAC 
control. 24 h after EAC transplantation, Group-III and IV received MEHS 
at a dose of 50 and 100 mg/kg i. p. for nine consecutive days, 
respectively. Group-V received reference drug 5-FU (20 mg/kg i. p.) for 
nine consecutive days [11].  
Twenty four hours of the last dose and 18 hr of fasting, 6 animals of 
each group were sacrificed by cervical dislocation to measure 
antitumor, haematological and biochemical parameters (livers) and 
rest of the animals were kept with food and water ad libitum to 
check percentage increase life span of the tumor host. The anti 
cancer activity of MEHS was measured in EAC animals with respect 
to the following parameters. 
Determination of tumor volume, packed cell volume and tumor 
weight 
The mice were dissected and the ascitic fluid was collected from the 
peritoneal cavity. Tumor volume, packed cell volume and tumor 
weight was measured according to the previously described 
standard methods in our laboratory [12]. 
Determination of viable and non-viable tumor cell count 
The viable and nonviable cells were counted in neubauer chamber 
like white blood cell counting procedure according to the previously 
used standard methods [12].  
Determination of percentage increase life span (% ILS) 
The effect of MEHS on percentage increased in life span was 
calculated on the basis of the mortality rates of the experimental 
mice according to the standard protocol [12]. 
Determination of hematological parameters 
Collected blood was used for the estimation of haemoglobin (Hb) 
content, red blood cell count (RBC) and WBC according to the 
standard protocol [13]. 
Serum biochemical parameter like total proteins, serum glutamate 
oxaloacetate transaminase (SGOT), serum glutamate pyruvate 
transaminase (SGPT), serum alkaline phosphatase (SALP) and serum 
bilirubin was done by using commercially available kits 
manufactured by the Span Diagnostics Ltd., Surat, India. 
Determination of tissue antioxidant parameters 
The tissue antioxidant assay was performed with liver tissues and the 
evaluation was carried out by measuring the level thiobarbituric acid 
reactive substances (TBARS) in lipid peroxidation assay, the amounts 
of enzymatic Catalase, superoxide dismutase and non enzymatic 
antioxidant system such as reduced glutathione [14, 15]. 
Statistical analysis 
Statistical analysis was performed using Graph Pad Prism (version 
5.0, Graph Pad Software Inc., San Diego, CA) Software. The 
experimental results were expressed as mean ± standard error of 
mean (SEM). Statistical significance was analyzed by one-way 
ANOVA followed by Dunnett’s post hoc test of significance. p < 0.05 
was considered as statistically significant. 
RESULTS 
Determination of in vitro cytotoxicity  
In the assay for in vitro cytotoxicity study, Trypan blue exclusion 
assay and MTT assay on MEHS showed the direct cytotoxic effect on 
the EAC cell line in a dose dependent manner with IC50 value of 43.2 
µg/ml and 50.3 µg/ml respectively (fig. 1 and fig. 2). 
Determination of acute toxicity 
The extract was safe up to the dose of 800 mg/kg for mice. Dose was 
selected on the basis of 1/10th of the LD50 
Hematological parameters of tumor bearing mice were found to be 
significantly altered as compared to normal control and MEHS at the 
dose 50 mg/kg and 100 mg/kg table. 2. 
dose (50 and 100 mg/kg). 
Determination of direct tumor related parameters 
Anticancer activity of MEHS at the dose 50 mg/kg and 100 mg/kg, 
against EAC tumor bearing mice was assessed by tumor volume, 
tumor weight, viable and non-viable cell count, mean survival time 
and % increase in life span. The tumor volume, tumor weight and 
viable cell count were found significantly increased and non- viable 
cell count was significantly reduced (p < 0.05) in EAC control 
animals when compared with normal control animals and treated 




Fig. 1: Cytotoxic effect of MEHS on in vitro EAC cell line by Trypan 
blue. Values are Mean ± SEM; where n = 6 
Fig. 2: Cytotoxic effect of MEHS on in vitro EAC cell line by MTT 
assay. Values are Mean ± SEM; where n = 6 
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Table 1: Effect of MEHS on tumor volume, tumor weight, total cell count, viable and nonviable cell count, mean survival time (MST) and 
percentage increase life-span (% ILS) in EAC bearing mice 
Parameters EAC Control  
(2 × 106
EAC + MEHS 
cells/mouse) (50 mg/kg)  
EAC + MEHS  
(100 mg/kg) 
EAC + 5-FU  
(20 mg/kg) 
Tumor volume (ml) 2.36± 0.06 1.02± 0.13*  0.75± 0.10*  0.55± 0.05* 
Tumor weight (g) 4.97± 0.36 1.67± 0.56*  1.12± 0.28* 0.51± 0.04* 
Total cell 8.49 × 106 4.69 × 10±0.07 6 2.54 × 10± 0.27*  6 3.81 × 10± 0.09* 6
Viable cell 
± 0.09* 
8.19 × 106 3.11 × 10±1.20 6 0.99 × 10± 0.27*  6 0.60 × 10± 0.08* 6
Nonviable cell 
± 0.08* 
0.40 × 106 2.11 × 10±0.06 6 1.34 × 10± 0.15*  6 3.21 × 10± 0.05* 6
MST (days) 
± 0.09* 
21 34*  43* 53* 
% ILS 00 61.90 104.76 152.38 
Statistical significance (p) calculated by one way ANOVA between EAC control group and the treated groups followed by Dunnett’s test (* p < 0.05). 
Each point represents the mean±SEM. (n = 6 mice per groups) 
 
Table 2: Effect of MEHS on hematological parameters in EAC bearing mice 
Parameters Normal saline  
(5 ml/kg) 
EAC control  
(2 × 106
EAC + MEHS 
 cells/mouse) (50 mg/kg)  
EAC + MEHS  
(100 mg/kg) 
EAC + 5-FU  
(20 mg/kg) 
RBC (cell × 106/mm3 5.29 ± 0.20 ) 1.63 ±0.09 4.83 ±0.08*  3.53 ±0.25* 5.19 ±0.20* 
WBC (cell × 103/mm3 4.98 ± 0.32 ) 7.84 ±1.13 4.70 ±0.62*  4.25 ±0.65* 5.09 ±0.33* 
Hb. (g/dL) 11.48 ±0.38 4.23 ±0.14 6.9 ±0.12* 8.4 ±0.21* 10.35 ±0.46* 
Statistical significance (p) calculated by one way ANOVA between EAC control group and the treated groups followed by Dunnett’s test (* p < 0.05). 
Each point represents the mean±SEM (n = 6 mice per groups) 
 
Serum biochemical parameters 
The serum biochemical parameters like amount of SGOT, SGPT and 
SALP in the EAC control group were significantly (p < 0.05) 
increased as compared to the normal control group and MEHS at the 
dose 50 mg/kg and 100 mg/kg. The total protein content was found 
to be significantly (p < 0.05) declined in the EAC control group when 
compared with the normal control group (table 3). 
 
Table 3: Effect of MEHS on serum biochemical parameters in EAC bearing mice 
Parameters Normal saline  
(5 ml/kg) 
EAC control  
(2 × 106
EAC + MEHS  
 cells/mouse) (50 mg/kg) 




10.84 ± 0.62 19.96 ± 0.86 9.61 ± 0.79* 11.14±0.35* 8.53 ± 0.33* 
SGPT 
(IU/l) 
15.45 ± 0.29 2.35 ± 0.73 19.05± 0.60* 22.73±0.62* 18.30 ± 0.56* 
SALP 
(IU/l) 
76.87 ± 1.70 200.1 ± 3.89 117.20±2.12* 127.8±1.53* 104.20 ± 4.46* 
Protein 
(g/dL) 
9.36 ± 0.14  4.63 ± 0.22 7.22 ± 0.17* 6.62± 0.27* 8.51 ± 0.11* 
Statistical significance (p) calculated by one way ANOVA between EAC control group and the treated groups followed by Dunnett’s test (* p < 0.05). 
Each point represents the mean±SEM (n = 6 mice per groups) 
 
Tissue antioxidant assay parameters 
The level of lipid peroxide in liver tissue was significantly 
increased in EAC control mice when compared to normal control 
animals. After treatment with MEHS (50 and 100 mg/kg b. w.), 
MDA content of liver and were significantly reduced with 
compared to EAC control mice (fig. 3). Liver homogenates of EAC 
control group the SOD activity was reduced as compared to the 
normal controls. The dose dependent enhancement of SOD was 
observed in case of MEHS treatment group, as compared with 
EAC control group (fig. 3). The reduction in antioxidant enzyme 
catalase activity in EAC control mice was improved in the liver 
by the treatment with MEHS (fig. 3). The reduced GSH level in 
liver was depleted in EAC control group. Treatment with MEHS 
significantly elevated reduced GSH level in a dose dependent 
manner (fig. 3). 
DISCUSSION 
In the present study, EAC cell line was used to evaluate the 
anticancer activity of MEHS. EAC or Ehrlich Ascites Carcinoma cells 
are spontaneous murine mammary rapidly growing 
adenocarcinoma cells which are highly aggressive in nature and can 
affect almost all strains of mice. The Ehrlich Ascitic tumor 
implantation induces a local inflammatory reaction with increasing 
vascular permeability, which results in an intense edema formation, 
cellular migration and a progressive ascitic fluid formation and 
accumulation [16]. The ascitic fluid is essential for tumor growth, 
since it constitutes a direct nutritional source for tumor cells [17]. 
MEHS treatment was able to reduce tumor volume, packed cell 
volume, viable cell count when compared to the tumor control group 
probably due to its potency in inhibiting the peritoneal ascitic fluid. 
These results could connote either a direct cytotoxic effect of MEHS 
on tumor cells or an indirect local effect, which may involve 
macrophage activation and vascular permeability inhibition [11]. 
Increase in life span of the treated animals is a reliable criterion for 
judging the value of any anticancer drug [3]. The MEHS treated group 
showed an enhancement of life span compared to the tumor treated 
group which indicates that MEHS could certainly be a potential 
candidate for an anticancer drug. The major problems faced during 
cancer chemotherapy are myelosuppression and anemia [18, 19]. 
Anemia occurs due to reduction in RBC or destruction of hemoglobin. 
Treatment with MEHS significantly restored RBC and hemoglobin 
towards their respective normal levels as compared to the tumor 
control group. Also the WBC cell count which elevated in the tumor 
induced group was brought down to near normal levels following 
MEHS treatment. Enzymes in serum have been studied for many 
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years as possible early indicators of neoplasia and as aids in 
following the progression and regression of disease [20]. 
Hepatotoxicity may occur due to cytotoxic agent itself or due to its toxic 




Fig. 3: Effect of MEHS on tissue antioxidant defense parameters like lipid peroxidation (A), superoxide dismutase (B), catalase (C), reduce 
glutathione (D) in EAC bearing mice. Values are represented as mean± SEM, where n=6. anormal control groupvsEAC control group, *p < 
0.05; b
 
 EAC control group vs All treated groups, *p < 0.05 
From the experiment, we found that EAC control group exhibited 
increased levels of liver enzymes such as SGOT, SGPT and ALP while 
the levels of total protein were decreased due to hepatocellular 
damages. The MEHS treated group showed restoration of these 
biochemical parameters to more or less normal levels. The 
misbalance between the reactive oxygen metabolites and the 
antioxidant defence systems leads to ‘oxidative stress’ which 
deregulates various cellular functions causing pathological 
conditions [21, 22]. The oxidative stress may lead to damage of the 
macromolecules such as lipids and can induce lipid peroxidation in 
vivo [23]. In EAC bearing mice, the level of lipid peroxide in the liver 
was significantly elevated, which was however reduced to near 
normal level in the MEHS treated group animals.  
This reflects the ability of the extract to decrease free radical 
production and to subsequently reduce the oxidative stress. 
Glutathione (GSH), a potent inhibitor of neoplastic proliferation 
process, plays a crucial role as an endogenous antioxidant system. It 
was found particularly in high concentration in liver and is known to 
have a key function in the protective process [24]. The level of non 
enzymatic antioxidant reduced glutathione (GSH) was reduced in 
cancer bearing mice which may be due to its utilization by the 
excessive amount of free radicals generated in the disease state. 
Treatment with MEHS was found to increase the GSH content in the 
liver as compared to the tumor control group. The free radical 
scavenging antioxidant system of endogenous enzymatic 
antioxidants (SOD and CAT) are present in all oxygen-metabolizing 
cells, and their function is to provide a defence against the 
potentially damaging reactivates oxygen species like superoxide 
anion free radical and hydrogen peroxide [25]. Inhibition of SOD and 
CAT activity as the result of EAC induced tumor was reported earlier 
[12]. Treatment with MEHS significantly increased the SOD and CAT 
levels indicating antioxidant and free radical scavenging activity of 
the extract.  
CONCLUSION 
The result of the present investigation is quite encouraging and it 
explores the potent anticancer activity of MEHS probably because of 
its direct cytotoxic effect which is further potentiated by its 
antioxidant properties. Further investigation was going on to find 
out the molecular mechanism for which anticancer activity shown. 
ACKNOWLEDGEMENT 
We greatly acknowledge the Department of Pharmaceutical 
Technology, Jadavpur University, Kolkata, India and Department of 
HC, HS & FW. Ayush, Singtam, Govt. of Sikkim, India. 
CONFLICT OF INTERESTS 
Declared None 
REFERENCES 
1. Saha P, Mazumder UK, Haldar PK, Naskar S, Kundu S, Bala A, et 
al. Anticancer activity of methanol extract of Cucurbita maxima 
against Ehrlich ascites carcinoma. Int J Res Pharm Sci 
2011;2(1):52–9. 
2. Globocan certified [Internate]. Estimated cancer incidence, 
Mortality and Prevelence worldwide in 2012. Available from: 
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. [Last 
accessed on 2013 Dec 18] 
3. Gupta M, Mazumder UK, Kumar RS, Sivakumar T, Vamsi MLM. 
Antitumor activity and antioxidant status of Caesalpinia 
bonducella against Ehrlich ascites carcinoma in Swiss albino 
mice. J Pharmacol Sci 2004;94:177–84.  
4. Dhyania D, Maikhuria RK, Misra S, Rao KS. Endorsing the 
declining indigenous ethnobotanical knowledge system of Sea 
buckthron in Central Himalaya, India. J Ethnopharmacol 
2010;127:329–34. 
Haldar et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 8, 180-184 
184 
5. Zeb A. Important therapeutic uses of sea buckthorn 
(Hippophae): a review. J Biol Sci 2004;5:687–93. 
6. Gupta SM, Gupta AK, Ahmed Z, Kumar A. Antibacterial and 
antifungal activity in leaf, seed extract and seed oil of sea 
buckthron (Hippophae salicifolia D. Don) plant. J Plant Pathol 
Microbiol 2011;2:2–4. 
7. Goyal AK, Basistha BC, Sen A, Middha SK. Antioxidant profiling 
of Hippophae salicifolia growing in sacred forests of Sikkim, 
India. Funct Plant Biol 2011;38:697–701. 
8. Dolai N, Karmakar I, Kumar RBS, Kar B, Bala A, Haldar PK. 
Evaluation of antitumor activity and in vivo antioxidant status 
of Anthocephalus cadamba on Ehrlich ascites carcinoma treated 
mice. J Ethnopharmacol 2012;142:865–70. 
9. Biswas M, Mondal NB, Patil P, Ghosh AK, Banerje S, Haldar PK. 
In vitro antitumor activity of pentacyclic triterpinoid compound 
isolated from fruit of Dregea valublis. TJPR 2009;8:127–31. 
10. OECD. Guidelines for the testing of chemicals/section 4:Health 
effects test No. 425:Acute oral toxicity: up-and-down 
procedure. Paris: Organisation for economic co-operation and 
development publishing; 2008. 
11. Bala A, Kar B, Haldar PK, Majumder UK, Bera S. Evaluation of 
anticancer activity of Cleome gynandra on Ehrlich’s ascites 
carcinoma treated mice. J Ethnopharmacol 2010;129;131–4. 
12. Karmakar I, Dolai N, Kumar RBS, Kar B, Roy SN, Haldar PK. 
Antitumor activity and antioxidant property of Curcuma caesia 
against Ehrlich’s ascites carcinoma bearing mice. Pharm Biol 
2013;51(6):753–9.  
13. Kumar RBS, Kar B, Dolai N, Karmakar I, Haldar S, Bhattacharya 
S, et al. Antitumor activity and antioxidant role of Streblus asper 
bark aganist Ehrlich’s ascites carcinoma in Swiss albino mice. J 
Exp Ther Oncol 2013;10(3):197–202. 
14. Naskar S, Mazumder UK, Pramanik G, Gupta M, Kumar RBS, 
Bala A, et al. Evaluation of antihyperglycemic activity of Cocos 
nucifera Linn. on streptozotocin induced type 2 diabetic rats. J 
Ethnopharmacol 201;138:769–73.  
15. Kakkar P, Das B, Vishwanath PN. A modified 
spectrophotometric assay of superoxide dismutase. Indian J 
Biochem Biophys 1984;21:130–2.  
16. Karmakar I, Haldar S, Chakraborty M, Chaudhury K, Dewanjee 
S, Haldar PK. Regulation of apoptosis through bcl-2/bax 
proteins expression and DNA damage by Zanthoxylum alatum. 
Pharm biol 2015;1:1-6. 
17. Shimizu M, Azuma C, Taniguchi T, Murayama T. Expression of 
cytosolic phospholipase A2α in murine C12 cells, a variant of 
L929 cells, induces arachidonic acid release in response to 
phorbol myristate acetate and Ca2+ ionophores, but not to 
tumor necrosis factor-α. J Pharmacol Sci 2004;96:324–32. 
18. Price VE, Greenfield RE. Anemia in cancer. In: Greenstein JP, 
Haddow A. Eds. Advances in cancer research. New York: 
Academic Press; 1958. p. 199–200. 
19. Maseki M, Nishigaki I, Hagishara M, Tomada Y, Yagi K. Lipid 
peroxide levels and lipid content of serum lipoprotein fractions 
of pregnant subjects with or without preeclampsia. J Clin Chim 
Acta 1981;41:424–6. 
20. Kathiriya K, Das EP, Kumar KB. Mathai Evaluation of antitumor and 
antioxidant activity of Oxalis corniculata Linn. against Ehrlich 
ascites carcinoma on mice. Iran J Cancer Prev 2010;3:157–65. 
21. Bandyopadhyay U, Das D, Banerjee RK. Reactive oxygen 
species: Oxidative damage and pathogenesis. Curr Sci 
1999;77:658. 
22. Adesegun SA, Fajana A, Orabueze CI, Coker HAB. Evaluation of 
antioxidant properties of Phaulopsis fascisepala C.B.Cl. 
(Acanthaceae). eCAM 2009;6(2):227–31. 
23. Yagi K. Lipid peroxides and human diseases. Chem Physiol Lip 
1991;45:337–51. 
24. Haldar PK, Kar B, Bala A, Bhattacharya S, Mazumder UK. Antitumor 
activity of Sansevieria roxburghiana rhizome against Ehrlich’s 
ascites carcinoma in mice. Pharm Biol 2010;48:1337–43. 
25. Karmakar I, Haldar S, Chakraborty M, Chaudhury K, Dewanjee S, 
Haldar PK. Antioxidant and cytotoxic activity of different extracts of 
Zanthoxylum Alatum. Free Radicals Antioxid 2015;5:21–8. 
 
